A B S T R A C T Pulmonary effluent samples were obtained from 26 preterm or term infants throughout the period of endotracheal intubation. Infants with respiratory distress syndrome, infants with this disorder developing bronchopulmonary dysplasia, and intubated infants without lung disease were compared daily in terms of lung effluent cellularity, albumin, elastase activity, a1-proteinase content and activity, and elastase inhibitory capacity. The elastase activity was determined to be neutrophilic in origin. Polyacrylamide gel electrophoresis of pulmonary effluents from two infants with respiratory distress syndrome and exposed to FiO2 5 0.6 up to 6 d revealed cleavage of oal-proteinase inhibitor to a 47,000-mol weight fragment suggestive of oxidation. Pulmonary effluent neutrophils, macrophages, and elastase activity were increased by day 3 of life in infants with respiratory distress syndrome eventually developing bronchopulmonary dysplasia. Elastase inhibitory capacity and a1-proteinase inhibitor activity were reduced in infants developing chronic lung disease. Bronchopulmonary dysplasia developed in infants with enhanced inflammatory response, but with less or inhibited antiprotease activity.
and elastase inhibitory capacity. The elastase activity was determined to be neutrophilic in origin. Polyacrylamide gel electrophoresis of pulmonary effluents from two infants with respiratory distress syndrome and exposed to FiO2 5 0.6 up to 6 d revealed cleavage of oal-proteinase inhibitor to a 47,000-mol weight fragment suggestive of oxidation. Pulmonary effluent neutrophils, macrophages, and elastase activity were increased by day 3 of life in infants with respiratory distress syndrome eventually developing bronchopulmonary dysplasia. Elastase inhibitory capacity and a1-proteinase inhibitor activity were reduced in infants developing chronic lung disease. Bronchopulmonary dysplasia developed in infants with enhanced inflammatory response, but with less or inhibited antiprotease activity. INTRODUCTION Resolution of severe neonatal respiratory distress syndrome (RDS)l may be manifested by recovery of normal lung function and structure, but may be instead associated with epithelial metaplasia of the bronchioles, interstitial and peribronchial smooth muscle proliferation, alveolar inflammation, and interstitial fibrosis with lobular distention by emphysematous foci (1) . Clinically affected infants require prolonged oxygen therapy because of hypoxemia and have a postneonatal course often complicated by hypercapnia, cor pulmonale, and frequent respiratory infections (2). 5-30% of infants with RDS develop radiographic evidence of this chronic lung disease. The disease, termed bronchopulmonary dysplasia (BPD) (3, 4) exhibits well-defined radiographic (5, 6) , pathologic (7) , and cytologic features (8) .
Although histopathologic studies of infants dying from RDS document an evolving pattern of pulmonary inflammation during the first week before demise (9) , current advances in neonatal ventilatory care have dramatically decreased the number of very premature infants who die from RDS. Despite these advances, it ' Abbreviations used in this paper: BPD, bronchopulmonary dysplasia; DFP, diisopropylfluorophosphate; ajPI, alproteinase inhibitor; PMSF, phenylmethylsulfonyl fluoride; RDS, respiratory distress syndrome; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
is not possible to predict the outcome of ventilatory therapy in terms of the development of BPD because precise measures are unavailable that predict the extent of lung injury from prolonged oxygen therapy, ventilation with high mean airway pressures, pulmonary plethora from patent ductus arteriosus, or pulmonary airleaks.
Attempts to lessen the frequency and severity of BPD have been unsuccessful, possibly, in part, because of imperfect understanding of the pathogenetic factors that produce lung injury. Although the antioxidant vitamin E has a theoretical basis in reducing lipid peroxidation (10) that justified clinical trials, early enthusiasm for this agent (11) has been unsupported in further studies (12, 13) .
Evidence that inflammatory cells are abundant in the lung effluent of infants ventilated for RDS (14, 15) has suggested a role of such cells in lung injury. Animal studies using hyperoxic environments have suggested that the resulting edematous lung injury can be lessened or prevented with neutrophil depletion using a variety of agents (16, 17) . Studies on lung injury models related to adult RDS suggest that toxic oxygen radicals may be derived from neutrophils stimulated to release superoxide anion, arachidonate metabolites produced by the activated neutrophils, and from exposure to the reduction of molecular oxygen used in the treatment-of the disorder.
Recent investigations of bronchoalveolar lavage in adults with RDS have demonstrated high concentrations of neutrophilic elastase in most patients as well as a reduction in the concentration of "active" a1-protease inhibitor (a,PI) in lavage material (19, 20) . The inactive a1PI was found to have been oxidized (21) . Observations by Bruce et al. (22) suggest that infants exposed to high FiO2 concentrations (>0.4) for [3] [4] d required greater amounts of a1PI to porcine pancreatic elastase (a measure of elastase inhibition) to achieve a 15% inhibition of elastase than infants exposed up to 9 d to lower FiO2 (20.4). Furthermore, Bruce et (25) .
Severe RDS was characterized by the requirement for supplemental oxygen, retractions of the chest wall, and expiratory grunting (26) . The chest radiograph demonstrated a typical reticulogranular pattern with air bronchograms or pulmonary "white-out" obscuring the heart borders (27) . Within the first hours of life, the infants with severe RDS required FiO2> 0.6 because of arterial oxygen pressure (PaO2) < 50 and/or a arterial CO2 pressure (PaCO2) > 60 torr, thus requiring endotracheal intubation and mechanical ventilation. BPD was identified using both tracheal aspirate cytologic features and radiographic evidence of the disorder (6, 8) .
Infants with conditions requiring endotracheal intubation and assisted ventilation, but generally free of lung disease, constituted a comparison group. These included patients with gastroschisis, birth trauma with hemidiaphragmatic paralysis, asphyxia, ascites from congenital renal disease, and preterm infants requiring mechanical ventilation for apnea. In all infants with RDS, amniotic fluid or tracheal effluent phospholipid profiles documenting lecithin/sphingomyelin ratios < 2.0 and absence of phosphatidylglycerol were obtained (28 (29) . The respective antibodies were incorporated at appropriate dilution in 1% agarose and poured onto leveled glass plates. Wells, cut by template, were filled with 5 Il pulmonary effluent or with varied concentrations of purified albumin or a,PI. Immunoelectrophoresis occurred using 20 V/cm at 24 mA (LKB) for 3 h at 4°C using a circulating antifreeze bath beneath the agarose gels. Following electrophoresis, the agarose gels were eluted with saline for 20 min and then dried in a standard manner, stained using 0.1% Coomassie Brilliant Blue R-250, and destained in 10% glacial acetic acid in ethanol. Following partial drying, each gel was placed on Gel-Bond (Bioproducts, Inc., Warrenton, OR) for preservation. a1PI was purified from infant pulmonary effluent according to the technique of Cochrane et al. (21) . Briefly, immunopurified goat anti-alPI antibody was covalently coupled to cyanogen bromide-activated Sepharose 4B beads. Pulmonary effluent was diluted to contain 92 Ag/ml of a,PI, a quantity necessary for detection by staining, in a slurry of Sepharose 4B containing covalently coupled anti-alPI and incubated at 25°C for 1 h. The beads were centrifuged and washed four times with 1 M NaCl in phosphate-buffered saline. The washed beads were eluted with 15 Al 10% SDS for 3 min at 100°C. After centrifugation of the beads, supernatant samples containing native elastase, bound and cleaved a,PI, were analyzed by electrophoresis in polyacrylamide gels containing SDS according to the method of Laemmli (30) . Gels were fixed and stained using 0.1% Coomassie Brilliant Blue R-250.
Elastase activity. Elastase activity was determined in pulmonary effluent by the elastin-agar plate method (31) and by using cleavage of methylosysuccinyl-L-(alanyl)3-prolylvalyl-p-nitroanilide peptide substrate according to the technique of Yusutake and Powers (32) . Briefly, 20 Ml of pulmonary effluent was reacted with 0.3 mM peptide substrate in 0.2 M Tris with 1 mg/ml of bovine serum albumin (pH 8.0). After 15 min incubation, the reaction was stopped using 500 ,ul of 1 N acetic acid, and the change in optical density at 410 nm vs. a blank was measured using Beckman DU2 spectrophotometer (Beckman Instruments, Inc., Palo Alto, CA) with a Gilford 6051 recorder (Gilford Instrument Laboratories, Inc., Oberlin, OH).
Serine elastase activity was determined by measurement of the change in optical density at 410 nm between the initial elastase activity and after preincubation of pulmonary effluent with 10 mM DFP or PMSF for 30 min at 370C. Inhibition of metalloelastase activity in pulmonary effluent using 10 mM EDTA and 10 mM, 1,10 phenathroline was similarly measured. 2 Elastase inhibitory capacity. The capacity of pulmonary effluent to inhibit elastase activity was measured in tracheal aspirates of infants daily. All assays were run in duplicate. Briefly, lung effluent (100 Il) was added to 0.2 M Tris buffer with 0.1 M CaC12 (pH 8.0). The inhibition of porcine pancreatic elastase activity against the peptide substrate 26.6 mM N-succinyl-L-(alanyl)3-p-nitroanilide in 0.92% N-methyl-2-pyrrolidinone was determined after a 2-h incubation at 37°C. The reaction was halted by addition of 200 Ml 1 N acetic acid and the differences in activities determined spectrophotometrically at 410 nm. Elastase inhibitory capacity was calculated as the percent reduction of 1.0 Mg/ml porcine pancreatic elastase plus endogenous elastase activity determined in pulmonary effluent (30) .
Statistical analysis of the pulmonary effluent studies with the unpaired Student's t test was used to compare data among the groups. A significant difference was assumed for a P < 0.05 on the unpaired test. Linear regression analysis using the statistical module of a Texas Instruments 59 calculator (Texas Instruments, Inc., Dallas, TX) was used to compare cell number and elastase activity. RESULTS Patient population. Table I lists characteristics of infants included in this report. Eight infants without primary lung disease were considered as "control" infants becuse they did not have RDS, chronic lung disease, or pneumonia, yet required endotracheal intubation and mechanical ventilation. Two of these infants were born at term and a single infant was exposed to general anesthesia (Halothane) for surgical repair of gastroschisis. No infant in this group had a pulmonary airleak.
12 infants had RDS and had an uneventful recovery of pulmonary function without radiographic evidence of BPD. Three of these RDS infants had pulmonary airleaks. Six additional infants with RDS, all having one or more airleaks, developed BPD. There was no significant difference between these two groups in terms of birth weight, gestational age, or Apgar scores. (Fig. 2) . Pulmonary albumin concentrations were significantly higher on day 1, possibly because of the inclusion of term infants in this sample. Albumin concentrations in lung effluent were not statistically different in the first week between RDS infants and those developing BPD.
Comparison of elastase activity among control infants during the first week of life revealed rather constant and low levels (>5.0 gg/mg albumin). To further characterize the cellular origins of the elastase(s) present in the infant pulmonary effluent, double-diffusion immunoprecipitation assays with rabbit-derived antibody to human neutrophilic elastase, as previously described by McGuire et al. (19) , revealed a distinct precipitin band from effluent containing 15 ysis of 10 samples from infants with RDS demonstrated that preincubation with either 10 mM DFP or PMSF resulted in a variable inhibition (75±29%) of elastase activity. Inhibition of peptide substrate determined elastase activity by 10 mM, 1,10 phenathroline was 20±9%, while 10 mM EDTA inhibited elastase activities >10%. These data suggest that serine elastase, presumably derived from neutrophilic leukocytes, was found in greater proportion than metalloelastase. Recent evidence (33), however, suggests that serine elastase may also be produced by monocytes within the lung and this cell cannot be excluded as contributing serine protease to the activity in pulmonary effluent. Because we observed a simultaneous increase in pulmonary effluent inflammatory cells and elastase activity, a comparison of inflammatory cell number (cells per cubic millimeter) to elastase activity (micrograms per milligram albumin) was made using all samples derived from all three groups. Analysis of this relationship, using regression analysis, failed to achieve a strong correlation (r = 0.41), suggesting that cell number in pulmonary effluent alone was insufficient to predict proteolytic activity.
Elastase inhibitory capacity. The capacity of lung effluent antiprotease to inhibit the activity of porcine pancreatic elastase was compared on daily basis among the infant groups (Fig. 4) The ability of pulmonary effluent a1PI to alter the activity of porcine pancreatic elastase using succinyl-L-(alanyl)3-p-nitroanilide peptide substrate was used to determine the activity of the protein presumably in its nonoxidized state. Table II compares (34) previously demonstrated that oxidized a1PI, but not native a1PI, underwent cleavage by elastase to yield a 47,000-D fragment. An 80,000-D band also found in the pulmonary effluent has previously been identified in pulmonary effluent of individuals with adult RDS to represent a1PI-elastase complex (29) .
Our finding of inactivated a1PI, cleavage of inactivated, presumably oxidized a1PI, and elastase-a1PI complex formation document that antiprotease activity can be substantially altered by the presence of elastase in pulmonary effluent and oxidation, presumably by exposure to high oxygen or neutrophil-derived oxidants.
DISCUSSION
Injury to lung connective tissues, primarily elastin and collagen, results when an imbalance between the elaboration of proteinases and the inhibitory capacity of proteins, primarily a1-globulins, exists in the lung.
Recent studies by Gadek et al. (35) have demonstrated that a1PI is the predominant inhibitor of neutrophil elastase in the regions of gas exchange in the lung of adult humans.
The precise interplay between immaturity, surfactant deficiency, oxygen exposure, mechanical ventilation, patency of the ductus arteriosus, and other factors in the pathogenesis of BPD has remained elusive. The potential role of lung inflammation accompanied 662 Merritt et al. Concomitant with elastase release, a1PI activity was substantially reduced in infants receiving high concentrations and longer durations and higher concentrations of oxygen exposure and mechanical ventilation. Absolute a1PI per milligram albumin was generally constant during the first days of life in lung effluent; however, both lung lavage and serum levels (data not shown) of a1PI activity fell in both RDS and RDS-BPD infants.
These observations, therefore, provide evidence that neutrophilic elastase activity unabated by proteinase inhibitor contributes to the development of chronic lung disease. Inactivation of a1PI has been demonstrated by Cochrane et al. (21) to occur by complex formation of neutrophilic elastase with a1PI and proteolytic cleavage of oxidized a1PI in adults with adult RDS. Using identical SDS-PAGE techniques to evaluate a1PI oxidation in infant tracheal aspirates, we found in infants developing chronic lung disease that elastase-a1PI complexes were formed and subsequently cleaved. These a1PI fragments were identified after 5-6 d of treatment. The presence of this 47,000-Da1PI fragment is consistent with evidence from RDS lavage fluids that oxidation of a1PI, presumably at the methionine peptide residue, and subsequent cleavage after elastase binding, occurs as previously demonstrated by Johnson and Travis (40) . Although it is not possible to totally exclude that elastase release, a1PI oxidation, and a1PI-elastin complex formation, occurred after the pulmonary secretions were removed from the neonates respiratory tract and maintained at 0°-4°C, immediate analysis after aspiration compared with analysis at 2 and 4 h after maintenance in a cold room varied <10%. Furthermore, elastase activity in infants with less severe RDS was very low when compared with infants with severe lung disease, and a1PI activity was found at significantly higher levels.
Although the infants developing BPD were exposed significantly longer to varying, but higher levels of FiO2, the precise etiology of the presumed oxidation occurring in infants' lungs remains unclear. Stimulated neutrophils have been shown to release oxidants sufficient to inactivate a1-proteinase and to suppress the elastase inhibitory capacity of plasma. Neutrophil myeloperoxidase, together with H202 and halide, has been shown to inactivate a1PI at the reactive site methionyl peptide according to Matheson et al. (41) .
Pulmonary edema during the first week of life has also been suggested as important in the pathogenesis of BPD. Preterm infants with RDS and immature lambs with oxygen exposure may have increased lung capillary permeability contributing to lung edema. (42) . Inappropriate fluid administration resulting in pulmonary edema was suggested by Brown et al. (43) to contribute to chronic lung disease; however, when controlling for daily fluid administration, Merritt et al. (44) found that ductus arteriosus patency, with leftto-right shunting, results in pulmonary edema (necessitating protracted assisted ventilation and higher FiO2 exposure) and was more frequently associated with BPD and death. Lung edema induced by toxic levels of oxygen has also been considered as contributory to the pathogenesis of chronic lung disease and may require the presence of neutrophils, although adult rabbits depleted of neutrophils have been reported to develop pulmonary edema and die in an environment of FiO2 of 1.0 in a time frame identical to nondepleted rabbits (45) .
Our observation that a1PI is inactivated presumably by oxidation occurring in the lung parenchyma and airways in infants undergoing treatment for RDS, suggests that oxidants are released by either the inflammatory cells or by direct molecular oxygen reaction within the cells. Elastase binding and subsequent inactivation of a1PI, thus, result in the inability to neutralize neutrophil-mediated elastase permitting elastin degradation. Pulmonary parenchymal elastin degradation by intratracheal instillation of porcine pancreatic elastase results in emphysematous changes with hyperinflation and interstitial fibrosis consistent with some of the pathologic features of BPD (46) . Elastin fragments have been shown to be chemotactic (47) for additional inflammatory cells as well as fibroblasts (48) . Oxidants are known to injure pulmonary tissue in sev-
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eral ways. Stimulated human neutrophils induce increased vascular permeability in isolated perfused rabbit lungs, while neutrophils from a patient with chronic granumomatous disease fail to generate oxidants after stimulation and did not increase vascular permeability (49) . In rats, intrapulmonary glucose, glucose oxidase, and lactoperoxidase induced acute pulmonary injury marked by an increased vascular permeability (50) . This injury was inhibited in a dosedependent manner by catalase. Xanthine and xanthine oxidase instilled intratracheally also causes pulmonary edema with partial inhibition by superoxide dismutase, but not catalase. These foregoing data strongly suggest that intrapulmonary generation of oxidants results in lung injury resulting in changes in vascular permeability previously documented in fetal sheep exposed to oxygen (51) . Exposure to high levels of inspired oxygen have also been implicated in the generation of oxidizing species generated in vivo. Infants developing BPD have been documented to have longer durations of FiO2 5 0.4 exposure; and duration of mechanical ventilation was longer in infants developing this disorder. Yet, it remains difficult to establish toxic "doses" of either inspired oxygen or airway pressure because these clinical variables are influenced by initial severity of RDS, differences in management, and fail to account for variability in the inflammatory response and protease inhibitory capacity among a host of varying clinical conditions including ductal left-to-right shunting, fluid administration, and sepsis.
Although additional data are required to clarify the quantitative roles of proteinase release, proteinase inhibition, and oxidant-induced injury in humans, this study documents that pulmonary effluent elastase concentration and proteinase inhibitory capacity can be used to identify infants with a strong chance of developing BPD later in their clinical course. Furthermore, these measures of lung injury may prove useful in evaluation of new modes of RDS intervention including high frequency oscillatory ventilation and surfactant supplementation.
Additional studies are also needed to clarify the role of other antiproteinases including a2-macroglobulin during oxygen exposure in preterm infants.
